Australia markets closed

Alpine Immune Sciences, Inc. (ALPN)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
10.41-1.02 (-8.92%)
At close: 04:00PM EST
10.35 -0.06 (-0.58%)
After hours: 04:35PM EST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
31/12/2017
Total revenue
24,556
9,335
1,740
705
1,731
Operating expenses
Research development
52,435
27,185
35,847
28,970
10,626
Selling general and administrative
13,065
10,899
9,467
8,362
6,079
Total operating expenses
65,500
38,084
45,314
37,332
16,705
Operating income or loss
-40,944
-28,749
-43,574
-36,627
-14,974
Interest expense
853
775
338
319
152
Total other income/expenses net
-
1,333
812
-1,203
6,601
Income before tax
-41,297
-27,946
-41,852
-36,853
-7,983
Income tax expense
211
-6
0
-366
-200
Income from continuing operations
-41,508
-27,940
-41,852
-36,487
-7,783
Net income
-41,508
-27,940
-41,852
-36,487
-7,783
Net income available to common shareholders
-41,508
-27,940
-41,852
-36,487
-7,783
Basic EPS
-
-1.34
-2.28
-2.63
-1.20
Diluted EPS
-
-1.34
-2.28
-2.63
-1.20
Basic average shares
-
20,826
18,359
13,849
6,482
Diluted average shares
-
20,826
18,359
13,849
6,482
EBITDA
-
-26,593
-41,046
-36,146
-7,590